|
CRIOPORT, Inc. (CYRX) DCF Valoración
US | Industrials | Integrated Freight & Logistics | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Cryoport, Inc. (CYRX) Bundle
¡Simplifique la valoración de CryoPort, Inc. (CYRX) con esta calculadora DCF personalizable! Con Real Cryoport, Inc. (Cyrx) Financials y las entradas de pronóstico ajustables, puede probar escenarios y descubrir el valor razonable de Cryoport, Inc. (CYRX) en minutos.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2018 |
AY2 2019 |
AY3 2020 |
AY4 2021 |
AY5 2022 |
FY1 2023 |
FY2 2024 |
FY3 2025 |
FY4 2026 |
FY5 2027 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 33.9 | 78.7 | 222.6 | 237.3 | 233.3 | 352.7 | 533.4 | 806.7 | 1,219.9 | 1,844.7 |
Revenue Growth, % | 0 | 131.86 | 182.87 | 6.59 | -1.7 | 51.22 | 51.22 | 51.22 | 51.22 | 51.22 |
EBITDA | -14.5 | -20.3 | -248.9 | -6.2 | -66.4 | -140.8 | -212.9 | -321.9 | -486.8 | -736.2 |
EBITDA, % | -42.68 | -25.81 | -111.81 | -2.61 | -28.45 | -39.91 | -39.91 | -39.91 | -39.91 | -39.91 |
Depreciation | 2.4 | 9.9 | 20.2 | 22.8 | 27.5 | 35.4 | 53.5 | 80.9 | 122.3 | 185.0 |
Depreciation, % | 7.12 | 12.54 | 9.1 | 9.59 | 11.78 | 10.03 | 10.03 | 10.03 | 10.03 | 10.03 |
EBIT | -16.9 | -30.2 | -269.2 | -29.0 | -93.8 | -169.7 | -256.7 | -388.1 | -587.0 | -887.6 |
EBIT, % | -49.8 | -38.35 | -120.91 | -12.2 | -40.23 | -48.12 | -48.12 | -48.12 | -48.12 | -48.12 |
Total Cash | 94.3 | 93.3 | 628.8 | 523.3 | 456.8 | 352.7 | 533.4 | 806.7 | 1,219.9 | 1,844.7 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 7.1 | 31.4 | 39.4 | 43.9 | 42.1 | 81.1 | 122.7 | 185.5 | 280.6 | 424.3 |
Account Receivables, % | 20.91 | 39.87 | 17.7 | 18.48 | 18.04 | 23 | 23 | 23 | 23 | 23 |
Inventories | .5 | 10.5 | 16.5 | 27.7 | 26.2 | 31.8 | 48.1 | 72.8 | 110.0 | 166.4 |
Inventories, % | 1.4 | 13.39 | 7.41 | 11.66 | 11.23 | 9.02 | 9.02 | 9.02 | 9.02 | 9.02 |
Accounts Payable | 2.5 | 24.3 | 27.7 | 27.0 | 26.1 | 51.7 | 78.2 | 118.3 | 178.8 | 270.4 |
Accounts Payable, % | 7.36 | 30.93 | 12.44 | 11.4 | 11.17 | 14.66 | 14.66 | 14.66 | 14.66 | 14.66 |
Capital Expenditure | -5.4 | -9.7 | -25.0 | -24.2 | -38.8 | -46.8 | -70.7 | -106.9 | -161.7 | -244.5 |
Capital Expenditure, % | -15.94 | -12.29 | -11.23 | -10.2 | -16.63 | -13.26 | -13.26 | -13.26 | -13.26 | -13.26 |
Tax Rate, % | -0.24057 | -0.24057 | -0.24057 | -0.24057 | -0.24057 | -0.24057 | -0.24057 | -0.24057 | -0.24057 | -0.24057 |
EBITAT | -17.0 | -30.1 | -270.8 | -30.8 | -94.1 | -169.7 | -256.6 | -388.0 | -586.8 | -887.4 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -25.0 | -42.4 | -286.2 | -48.5 | -103.1 | -200.1 | -305.2 | -461.5 | -697.9 | -1,055.4 |
WACC, % | 8.13 | 8.13 | 8.13 | 8.13 | 8.13 | 8.13 | 8.13 | 8.13 | 8.13 | 8.13 |
PV UFCF | ||||||||||
SUM PV UFCF | -2,035.7 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -1,077 | |||||||||
Terminal Value | -17,563 | |||||||||
Present Terminal Value | -11,882 | |||||||||
Enterprise Value | -13,917 | |||||||||
Net Debt | 370 | |||||||||
Equity Value | -14,287 | |||||||||
Diluted Shares Outstanding, MM | 49 | |||||||||
Equity Value Per Share | -293.14 |
What You Will Get
- Real CYRX Financial Data: Pre-filled with Cryoport’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Cryoport’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive CYRX Data: Pre-loaded with Cryoport’s historical performance metrics and future projections.
- Customizable Financial Inputs: Modify revenue growth rates, profit margins, WACC, tax rates, and capital expenditures as needed.
- Interactive Valuation Model: Automatically recalculates Net Present Value (NPV) and intrinsic value based on user-defined inputs.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
- Intuitive User Interface: Designed for ease of use, catering to both seasoned professionals and newcomers.
How It Works
- Step 1: Download the prebuilt Excel template featuring Cryoport, Inc.'s (CYRX) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view updated results, including Cryoport, Inc.'s (CYRX) intrinsic value.
- Step 5: Make well-informed investment choices or create reports based on the outputs.
Why Choose This Calculator for Cryoport, Inc. (CYRX)?
- All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for Cryoport, Inc. (CYRX).
- Flexible Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes Cryoport, Inc.'s (CYRX) intrinsic value and Net Present Value.
- Preloaded Information: Access to historical and projected data for precise analysis.
- Expert-Level Resources: Perfect for financial analysts, investors, and business consultants focusing on Cryoport, Inc. (CYRX).
Who Should Use Cryoport, Inc. (CYRX)?
- Healthcare Professionals: Understand the logistics of temperature-controlled supply chains in the biopharmaceutical industry.
- Researchers: Utilize Cryoport's services to ensure the integrity of sensitive biological samples.
- Investors: Evaluate market trends and performance metrics related to Cryoport, Inc. (CYRX) for informed investment decisions.
- Pharmaceutical Companies: Optimize your shipping processes with Cryoport's specialized cold chain solutions.
- Regulatory Bodies: Ensure compliance with industry standards for the transportation of temperature-sensitive products.
What the Template Contains
- Historical Data: Includes Cryoport, Inc.’s (CYRX) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Cryoport, Inc.’s (CYRX) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Cryoport, Inc.’s (CYRX) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.